Low-dose methotrexate fails to lower CVD risk

Hopes of an anti-inflammatory benefit dashed

Hoping to tap the anti-inflammatory powers of methotrexate, researchers have failed to show that a low-dose of the drug, used to treat cancer and arthritis, can reduce the risk of heart attack or stroke.

# Tags